Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28683298.
- Also identified by DOI 10.1016/j.cmet.2017.06.016 and PMC identifier 5543711.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cancer immunotherapy is an increasingly successful strategy for the treatment of patients who have advanced or conventional therapy-resistant cancers. T cells are key mediators of tumor destruction and their specificity for tumor-expressed antigens is of paramount importance, but other T cell-intrinsic qualities, such as durability, longevity, and functionality also play important roles in determining the efficacy of immunotherapy. The cellular energetic pathways that are utilized by T cells play a key role in regulating each of these qualities. Metabolic activity, which both regulates and is regulated by cellular signaling pathways and epigenetics, also profoundly influences the trajectories of T cell differentiation and fate. In this Review, we discuss how cell metabolism influences T cell anti-tumor activity, the metabolic qualities of highly-functional T cells, and strategies to modulate metabolism for improving the immune response to tumors.
Medical subject headings
- Immunotherapy
- Metabolic Networks and Pathways
- Neoplasms
- T-Lymphocytes